Concentration of sRAGE, esRAGE and HMGB1 in serum of patients.

<p>The basic characteristics of patients with TETs, TH and healthy volunteers are detailed. Characterization and categorization of patients with TETs according to type of TET, tumor invasiveness and presence of MG: the corresponding sRAGE, esRAGE and HMGB1 concentration in serum of patients are reported is mean (median) ± standard deviation (standard error mean).</p>a<p><i>Post hoc</i> analysis: please see the corresponding figures.</p>b<p>independent-samples t-test</p>c<p>one-way ANOVA</p>d<p>Pearson's <i>χ²</i> test for independence</p><p><i>f:m ratio</i> female:male ratio, <i>RAGE</i> receptor for advanced glycation endproducts, <i>sRAGE</i> soluble RAGE, <i>esRAGE</i> endogenous secretory RAGE, <i>HMGB1</i> high mobility group box1, <i>TETs</i> thymic epithelial tumors, <i>MG</i> Myasthenia gravis, <i>SEM</i> standard error mean, <i>n</i> number of patients, <i>TH</i> thymic hyperplasia, <i>TC</i> thymic carcinoma